Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice T Shaw

Showing results (41-50 of 204) with videos related to

Pageof 21
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Pathology Issues in Thoracic Oncology: Histologic Characterization and Tissue/Plasma Genotyping May Resolve Diagnostic DilemmasIbiayi Dagogo-Jack, Andreas Saltos, Alice T Shaw, et al.
Cancer Discovery|April 28, 2025
Response and Resistance to RAS Inhibition in CancerRichard Y Ebright, Julien Dilly, Alice T Shaw, et al.
Nature Reviews. Cancer|October 18, 2013
Tyrosine kinase gene rearrangements in epithelial malignanciesAlice T Shaw, Peggy P Hsu, Mark M Awad, et al.
The New England Journal of Medicine|July 15, 2011
Case records of the Massachusetts General Hospital. Case 21-2011. A 31-year-old man with ALK-positive adenocarcinoma of the lungAlice T Shaw, David G Forcione, Subba R Digumarthy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Successful desensitization of two patients with ALK-positive lung cancer and hypersensitivity to crizotinibMark M Awad, Timothy P Lax, Benjamin R Slawski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
The central nervous system as a sanctuary site in ALK-positive non-small-cell lung cancerJustin F Gainor, Sai-Hong Ignatius Ou, Jennifer Logan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Dose Finding of Small-Molecule Oncology Drugs: Optimization throughout the Development Life CyclePasi A Jänne, Geoffrey Kim, Alice T Shaw, et al.
The Oncologist|June 30, 2016
Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung CancerMeghan Campo, Hani Al-Halabi, Melin Khandekar, et al.
Clinical Lung Cancer|June 6, 2019
Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-AnalysisDexter P Mendoza, Justin Stowell, Alona Muzikansky, et al.
Cancer|August 7, 2020
Association between circulating tumor DNA burden and disease burden in patients with ALK-positive lung cancerEric W Zhang, Ibiayi Dagogo-Jack, Anderson Kuo, et al.
Pageof 21

Showing results (41-50 of 204) with videos related to

Sort By:
Pageof 21
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Pathology Issues in Thoracic Oncology: Histologic Characterization and Tissue/Plasma Genotyping May Resolve Diagnostic DilemmasIbiayi Dagogo-Jack, Andreas Saltos, Alice T Shaw, et al.
Cancer Discovery|April 28, 2025
Response and Resistance to RAS Inhibition in CancerRichard Y Ebright, Julien Dilly, Alice T Shaw, et al.
Nature Reviews. Cancer|October 18, 2013
Tyrosine kinase gene rearrangements in epithelial malignanciesAlice T Shaw, Peggy P Hsu, Mark M Awad, et al.
The New England Journal of Medicine|July 15, 2011
Case records of the Massachusetts General Hospital. Case 21-2011. A 31-year-old man with ALK-positive adenocarcinoma of the lungAlice T Shaw, David G Forcione, Subba R Digumarthy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Successful desensitization of two patients with ALK-positive lung cancer and hypersensitivity to crizotinibMark M Awad, Timothy P Lax, Benjamin R Slawski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
The central nervous system as a sanctuary site in ALK-positive non-small-cell lung cancerJustin F Gainor, Sai-Hong Ignatius Ou, Jennifer Logan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Dose Finding of Small-Molecule Oncology Drugs: Optimization throughout the Development Life CyclePasi A Jänne, Geoffrey Kim, Alice T Shaw, et al.
The Oncologist|June 30, 2016
Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung CancerMeghan Campo, Hani Al-Halabi, Melin Khandekar, et al.
Clinical Lung Cancer|June 6, 2019
Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-AnalysisDexter P Mendoza, Justin Stowell, Alona Muzikansky, et al.
Cancer|August 7, 2020
Association between circulating tumor DNA burden and disease burden in patients with ALK-positive lung cancerEric W Zhang, Ibiayi Dagogo-Jack, Anderson Kuo, et al.
Pageof 21